BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17429350)

  • 1. Vaporization as a smokeless cannabis delivery system: a pilot study.
    Abrams DI; Vizoso HP; Shade SB; Jay C; Kelly ME; Benowitz NL
    Clin Pharmacol Ther; 2007 Nov; 82(5):572-8. PubMed ID: 17429350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis smoke condensate III: the cannabinoid content of vaporised Cannabis sativa.
    Pomahacova B; Van der Kooy F; Verpoorte R
    Inhal Toxicol; 2009 Nov; 21(13):1108-12. PubMed ID: 19852551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Abulseoud OA; Huestis MA
    Drug Alcohol Depend; 2017 Jun; 175():67-76. PubMed ID: 28407543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum cannabinoid levels 24 to 48 hours after cannabis smoking].
    Skopp G; Richter B; Pötsch L
    Arch Kriminol; 2003; 212(3-4):83-95. PubMed ID: 14639811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke.
    Mørland J; Bugge A; Skuterud B; Steen A; Wethe GH; Kjeldsen T
    J Forensic Sci; 1985 Oct; 30(4):997-1002. PubMed ID: 2999292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol.
    Hazekamp A; Ruhaak R; Zuurman L; van Gerven J; Verpoorte R
    J Pharm Sci; 2006 Jun; 95(6):1308-17. PubMed ID: 16637053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
    Jones AW; Holmgren A; Kugelberg FC
    Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
    Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
    Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.
    Ohlsson A; Lindgren JE; Wahlén A; Agurell S; Hollister LE; Gillespie HK
    Biomed Mass Spectrom; 1982 Jan; 9(1):6-10. PubMed ID: 6277407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma delta-9-tetrahydrocannabinol in pregnant sheep and fetus after inhalation of smoke from a marijuana cigarette.
    Abrams RM; Cook CE; Davis KH; Niederreither K; Jaeger MJ; Szeto HH
    Alcohol Drug Res; 1985-1986; 6(5):361-9. PubMed ID: 3011026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
    Clin Chem; 2015 Jun; 61(6):850-69. PubMed ID: 26019183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
    Eisenberg E; Ogintz M; Almog S
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Cozart DDSV test for cannabis in oral fluid.
    Kintz P; Brunet B; Muller JF; Serra W; Villain M; Cirimele V; Mura P
    Ther Drug Monit; 2009 Feb; 31(1):131-4. PubMed ID: 19155965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolyzed blood and serum levels of delta 9-THC: effects on the performance of roadside sobriety tests.
    Reeve VC; Robertson WB; Grant J; Soares JR; Zimmermann EG; Gillespie HK; Hollister LE
    J Forensic Sci; 1983 Oct; 28(4):963-71. PubMed ID: 6313846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis.
    Lanz C; Mattsson J; Soydaner U; Brenneisen R
    PLoS One; 2016; 11(1):e0147286. PubMed ID: 26784441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of cannabinoids in hair after long-term use of cannabis.
    Skopp G; Strohbeck-Kuehner P; Mann K; Hermann D
    Forensic Sci Int; 2007 Jul; 170(1):46-50. PubMed ID: 17098389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana smoking: effects of varying puff volume and breathhold duration.
    Azorlosa JL; Greenwald MK; Stitzer ML
    J Pharmacol Exp Ther; 1995 Feb; 272(2):560-9. PubMed ID: 7853169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.